• No results found

University of Groningen Improving treatment and imaging in ADPKD van Gastel, Maatje Dirkje Adriana

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Improving treatment and imaging in ADPKD van Gastel, Maatje Dirkje Adriana"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Improving treatment and imaging in ADPKD

van Gastel, Maatje Dirkje Adriana

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van Gastel, M. D. A. (2019). Improving treatment and imaging in ADPKD. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)

Maatje Dirkje Adriana van Gastel | Improving treatment and

imaging in ADPKD

ISBN: 978-94-034-1505-5 (printed version)

978-94-034-1504-8 (digital version)

Financial support by the University Medical Center Groningen,

Graduate School of Medical Sciences and the University of Groningen

for the publication of this thesis is gratefully acknowledged.

Financial support for the printing of this thesis was also kindly provided

by:

Cover design: Gerard te Wierik

Layout and design: Gerard te Wierik and Sylvia Faasse

Printing: Ridderprint BV | www.ridderprint.nl

© M.D.A. van Gastel 2019

All rights reserved. No part of this thesis may be reproduced, stored or

transmitted in any way or by any means without the prior permission of

the author.

(4)

Proefschrift

ter verkrijging van de graad van doctor aan de

Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

woensdag 29 mei 2019 om 14.30 uur

door

Maatje Dirkje Adriana van Gastel

geboren op 21 november 1988

te Deventer

Improving treatment and imaging

in ADPKD

(5)

PROMOTORES

Prof. dr. R.T. Gansevoort Prof. dr. V.E. Torres

COPROMOTOR Dr. E. Meijer BEOORDELINGSCOMMISSIE Prof. dr. M.H. Breuning Prof. dr. R.H. Henning Prof. dr. S.P. Berger

PARANIMFEN

E. Cornec-le Gall, MD, PhD L.R. Harskamp, MD

(6)
(7)

CONTENTS

Chapter 1 Introduction

Part I. Treating ADPKD by influencing the vasopressin pathway

Chapter 2 PKD and the vasopressin pathway Ann Nutr Metab 2017;70(suppl 1):43–50

Chapter 3 Modifiable factors associated with copeptin concentration:

a general population cohort

Am J Kidney Dis. 2015;65:719-727

Chapter 4 Modifiable factors associated with copeptin concentration in ADPKD

Submitted

Chapter 5 Copeptin to predict disease progression and tolvaptan efficacy

in ADPKD

Kidney International. 2019, Epub ahead of print

Chapter 6 Case report: A thiazide diuretic to treat polyuria induced by tolvaptan

BMC Nephrol. 2018;19:157

Chapter 7 Sodium intake and vasopressin V2 receptor antagonism versus disease progression in experimental PKD

In preparation 9 23 41 67 93 129 141

(8)

Part II. Optimization of total kidney and liver volume assessment in ADPKD to improve feasibility in clinic practice

Chapter 8 T1 versus T2 weighted magnetic resonance imaging to assess total kidney volume in patients with ADPKD

Abdom Radiol (NY). 2018;43:1215-1222

Chapter 9 Estimation of total kidney volume in ADPKD Am J Kidney Dis. 2015;66:792-801

Chapter 10 Automated segmentation of kidneys and liver in MR images of patients affected by polycystic kidney and liver disease J Am Soc Nephrol. Accepted for publication

Chapter 11 Summary, discussion and future perspectives

Addendum Nederlandse samenvatting / Dutch summary Dankwoord / Acknowledgements List of publications 163 185 211 235 247 257 265

(9)

Referenties

GERELATEERDE DOCUMENTEN

The various sensitivity analyses showed similar results for the associations of baseline copeptin with annual TKV growth rate and eGFR decline in untreated subjects, as well as

available treatment for autosomal dominant polycystic kidney disease (ADPKD), but there are tolerability issues due to aquaretic side-effects such as polyuria.. A

Long-term treatment with a low sodium diet ameliorated disease progression in a slowly progressive mouse model of PKD, and reduced the aquaretic side-effects of treatment while

Conclusions: In patients with ADPKD measurement of kidney volume and growth rate perform similarly when using T2 compared to T1 weighted images, although T2 performs better

Cohort for longitudinal analyses: Associations between percentage change in measured total kidney volume (mTKV) and percentage change in estimated total kidney volume (eTKV) using

We then compared the performance of manually and automated TKV and TLV meas- urements. First by comparing absolute as well as percentage differences between vol- umes measured

Further studies in patients with ADPKD should illuminate the potential of hydrochlorothiazide in ameliorating the rate of disease progression, as well as its potential in

De TEMPO 3:4 studie heeft aangetoond dat in patiënten met cystenieren het gebruik van tolvaptan, een medicijn dat het effect van vasopressine blokkeert in de nier, leidt